Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2487505 | Journal of Pharmaceutical Sciences | 2008 | 14 Pages |
Abstract
In this study, the hepatic metabolism and transport system for resveratrol was examined in isolated perfused livers from Wistar and Mrp2âdeficient TRâ rats. Based on extensive metabolism to six glucuronides and sulfates (M1-M6), the hepatic extraction ratio and clearance of resveratrol was very high in Wistar and TRâ rats (E: 0.998 vs. 0.999; Cl: 34.9 mL/min vs. 36.0 mL/min). However, biliary excretion and efflux of conjugates differs greatly in TRâ rats. While cumulative biliary excretion of the glucuronides M1, M2, M3, and M5 dropped dramatically to 0-6%, their efflux into perfusate increased by 3.6â, 1.8â, 2.5â, and 1.5âfold. In contrast, biliary secretion of the sulfates M4 and M6 was partially maintained in the Mrp2âdeficient rats (61% and 39%) with a concomitant decline of their efflux into perfusate by 33.2% and 78.1%. This indicates that Mrp2 exclusively mediates the biliary excretion of resveratrol glucuronides but only partly that of sulfates. Cumulative secretion of unconjugated resveratrol into bile of TRâ rats was only reduced by 40%, and into perfusate by 19%, suggesting only a minor role of Mrp2 in resveratrol elimination. In summary, resveratrol was doseâdependently metabolized to several conjugates whereby the canalicular transporter Mrp2 selectively mediated the biliary excretion of glucuronides. © 2007 WileyâLiss, Inc. and the American Pharmacists Association J Pharm Sci 97:1615-1628, 2008
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Alexandra MaierâSalamon, Birigt Hagenauer, Gottfried Reznicek, Thomas Szekeres, Theresia Thalhammer, Walter Jäger,